(As at October 11, 2024)
Nav Change
As at October 11, 2024
-1.37%
Market Price
(As at October 11, 2024 at 5:00pm)
N/A
AUM
 
EBIT provides investors with a simple and efficient way to access the price of bitcoin through a secure investment solution. The benefits of EBIT include:
EBIT
|
Evolve Bitcoin ETF |
|
TICKER
EBIT EBIT.U |
NAV* (11:00AM ET)
As at October 11, 2024 $29.90 (EBIT) $21.76 (EBIT.U)
|
NAV CHANGE
As at October 11, 2024 -1.37 -1.85
|
MARKET PRICE
(As at October 11, 2024 at 5:00pm)
EBIT
EBIT.U |
BTC PER SHARE
0.00035828 (EBIT)
0.0003586 (EBIT.U)
|
SHARES PER BTC
2,791.0934 (EBIT)
2,788.6469 (EBIT.U)
|
AUM
$219.352 M |
BTC PRICE (USD)**
(as at October 12, 2024, 02:01 pm) $63,106.56 |
Ticker / Fund |
Nav |
1D |
1M |
3M |
6M |
YTD |
1Y |
3Y |
5Y |
SI** |
---|---|---|---|---|---|---|---|---|---|---|
EBIT | $29.90 | -1.37% | 7.73% | 5.64% | -11.69% | 46.28% | 119.34% | 4.98% | -- | 4.52% |
EBIT.U | $21.76 | -1.85% | 6.56% | 4.60% | -12.19% | 40.27% | 116.90% | 1.61% | -- | 2.34% |
** Performance of EBIT and EBIT.U since inception on February 17, 2021.
Ticker/Fund | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
EBIT | - | - | - | - | -9.71% | -63.98% | 146.92% |
EBIT.U | - | - | - | - | -9.06% | -66.39% | 153.72% |
CUSIP 09175J108 (EBIT)09175J116 (EBIT.U) | TICKER EBITEBIT.U | LISTING EXCHANGE Toronto Stock Exchange (TSX). |
INCEPTION DATE February 17, 2021 | CURRENCY Unhedged to CAD (EBIT)USD (EBIT.U) | REGISTERED INVESTMENT ELIGIBILITY Yes |
INDEX CME CF Bitcoin Reference Rate (BRR) | INDEX PROVIDER CF Benchmarks Ltd |
MANAGEMENT FEE
0.75 |
OPTIONS TRADING AVAILABLE Yes - Montréal Exchange |
As at Oct 10, 2024
Wallet BreakdownAs at Oct 10, 2024
|
Sector AllocationAs at Oct 10, 2024
|
CF Benchmarks Ltd. - https://www.cfbenchmarks.com/solutions/banks We believe that robust indices of high integrity are essential to the development of the cryptocurrency asset class and its continued adoption by ever more individual and institutional investors. Our indices power a wide range of financial products including derivative contracts, investment funds and structured products. Combining indexing techniques that have been tried and tested in traditional asset classes with concepts unique to cryptocurrencies, furthering adoption of the asset class. Robust Processes and Technology. CF Benchmarks has developed state of the art technology to ensure its indices are provided to the utmost precision in a timely manner, 24/7. Its quality assurance processes ensure that the indices it provides are suitable for even the most demanding users. CF Benchmarks is committed to the highest degree of transparency in its administration of indices. Full index methodologies alongside our key policies are publicly available at https://www.cfbenchmarks.com/indices/BRTI and all announcements are made through our news channel. All indices are subject to independent oversight and minutes of oversight meeting are made publicly available. Our indices have been designed to facilitate replication both organically and through licensed financial products. Investors can gain exposure to the performance of our indices through leading financial institutions including; CME Group, Evolve Funds and WisdomTree. |
|
||||||
|
Evolve ETFs
Scotia Plaza, 40 King Street West, Suite 3404, Toronto ON M5H 3Y2
416.214.4884 | 1.844.370.4884 | evolveetfs.com
|
(As at October 11, 2024)
As at October 11, 2024
(As at October 11, 2024 at 5:00pm)
 
N/A
EBIT
Toronto Stock Exchange (TSX). Subject to TSX Approval.
Coming Soon
Unhedged to CAD
Yes
Bitcoin Reference Rate (BRR)
CF BENCHMARKS LTD
1.00%
09175J108
EBIT
Toronto Stock Exchange (TSX).
February 17, 2021
Unhedged to CAD
Yes
CME CF Bitcoin Reference Rate (BRR)
CF Benchmarks Ltd
0.75% (plus applicable sales taxes)
09175J116
EBIT.U
Toronto Stock Exchange (TSX).
February 17, 2021
USD
Yes
CME CF Bitcoin Reference Rate (BRR)
CF Benchmarks Ltd
0.75% (plus applicable sales taxes)
Investors who are:
* NAV calculated as at 11:00am (ET) each trading day.
** Source: CME CF Bitcoin Real-Time Index (BRTI).
Commissions, management fees and expenses all may be associated with exchange traded funds (ETFs). Please read the prospectus before investing. The indicated rates of return are the historical annual compound total returns net of fees (except for figures of one year or less, which are simple total returns) including changes in unit value and reinvestment of all distributions and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns. ETFs are not guaranteed, their values change frequently and past performance may not be repeated.
The rates of return shown in the table are used only to illustrate the effects of the compound growth rate and is not intended to reflect future values of the ETF or returns on investment in the ETF.
Investors should monitor their holdings, as frequently as daily, to ensure that they remain consistent with their investment strategies.
Ernst & Young LLP is the auditor of the Canadian Reporting Issuer investment funds managed by Evolve Funds Group Inc. (the “Funds”). Ernst & Young LLP is independent with respect to the Funds in the context of the CPA Code of Professional Conduct of the Chartered Professional Accountants of Ontario. For the year ended December 31, 2023, fees paid or payable to Ernst & Young LLP and its network firms for audit services to the Funds were $454,400. Fees for other services were $25,250.
CF BENCHMARKS LTD INDEX DATA IS USED UNDER LICENSE AS A SOURCE OF INFORMATION FOR CERTAIN EVOLVE FUNDS GROUP INC. PRODUCTS. CF BENCHMARKS LTD AND ITS AGENTS HAVE NO OTHER CONNECTION TO EVOLVE FUNDS GROUP INC. PRODUCTS AND SERVICES AND DO NOT SPONSOR, ENDORSE, RECOMMEND OR PROMOTE ANY EVOLVE FUNDS GROUP INC. PRODUCTS OR SERVICES. CF BENCHMARKS AND ITS AGENTS HAVE NO OBLIGATION OR LIABILITY IN CONNECTION WITH THE EVOLVE FUNDS GROUP INC. PRODUCTS AND SERVICES. CF BENCHMARKS AND ITS AGENTS DO NOT GUARANTEE THE ACCURACY AND/OR THE COMPLETENESS OF ANY INDEX LICENSED TO EVOLVE FUNDS GROUP INC. AND SHALL NOT HAVE ANY LIABILITY FOR ANY ERRORS, OMISSIONS, OR INTERRUPTIONS THEREIN.
As at October 11, 2024
Ticker / Fund
Nav
1D
1M
3M
6M
YTD
1Y
3Y
5Y
SI**
** Performance of EBIT and EBIT.U since inception on February 17, 2021.
Ticker/Fund | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
EBIT | - | - | - | - | -9.71% | -63.98% | 146.92% |
EBIT.U | - | - | - | - | -9.06% | -66.39% | 153.72% |
* NAV calculated as at 11:00am (ET) each trading day.
** Source: CME CF Bitcoin Real-Time Index (BRTI).
Commissions, management fees and expenses all may be associated with exchange traded funds (ETFs). Please read the prospectus before investing. The indicated rates of return are the historical annual compound total returns net of fees (except for figures of one year or less, which are simple total returns) including changes in unit value and reinvestment of all distributions and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns. ETFs are not guaranteed, their values change frequently and past performance may not be repeated.
The rates of return shown in the table are used only to illustrate the effects of the compound growth rate and is not intended to reflect future values of the ETF or returns on investment in the ETF.
Investors should monitor their holdings, as frequently as daily, to ensure that they remain consistent with their investment strategies.
Ernst & Young LLP is the auditor of the Canadian Reporting Issuer investment funds managed by Evolve Funds Group Inc. (the “Funds”). Ernst & Young LLP is independent with respect to the Funds in the context of the CPA Code of Professional Conduct of the Chartered Professional Accountants of Ontario. For the year ended December 31, 2023, fees paid or payable to Ernst & Young LLP and its network firms for audit services to the Funds were $454,400. Fees for other services were $25,250.
CF BENCHMARKS LTD INDEX DATA IS USED UNDER LICENSE AS A SOURCE OF INFORMATION FOR CERTAIN EVOLVE FUNDS GROUP INC. PRODUCTS. CF BENCHMARKS LTD AND ITS AGENTS HAVE NO OTHER CONNECTION TO EVOLVE FUNDS GROUP INC. PRODUCTS AND SERVICES AND DO NOT SPONSOR, ENDORSE, RECOMMEND OR PROMOTE ANY EVOLVE FUNDS GROUP INC. PRODUCTS OR SERVICES. CF BENCHMARKS AND ITS AGENTS HAVE NO OBLIGATION OR LIABILITY IN CONNECTION WITH THE EVOLVE FUNDS GROUP INC. PRODUCTS AND SERVICES. CF BENCHMARKS AND ITS AGENTS DO NOT GUARANTEE THE ACCURACY AND/OR THE COMPLETENESS OF ANY INDEX LICENSED TO EVOLVE FUNDS GROUP INC. AND SHALL NOT HAVE ANY LIABILITY FOR ANY ERRORS, OMISSIONS, OR INTERRUPTIONS THEREIN.
Annually, if any